Anebulo Pharmaceuticals (ANEB) Shares Issued (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Shares Issued of $2.0 million for Q4 2025, down 21.31% year-over-year from $2.6 million in Q4 2024, and up 5.26% quarter-over-quarter from $1.9 million in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Shares Issued (2020 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Shares Issued for 6 consecutive years, with $2.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Issued fell 21.31% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (down 21.31% YoY), while the FY2025 annual figure was $3.2 million, up 38.77% from the prior year.
- Shares Issued rose to $2.0 million in Q4 2025 per ANEB's latest filing, from $1.9 million in the prior quarter.
- Across five years, Shares Issued topped out at $3.2 million in Q2 2025 and bottomed at $81288.0 in Q4 2021.
- Historically, Shares Issued has averaged $1.7 million across 5 years, with a median of $1.9 million in 2022.
- Annual changes were most pronounced in 2022 — Shares Issued jumped 2434.34% — and 2023, when it tumbled 55.39%.
- Anebulo Pharmaceuticals' Shares Issued stood at $81288.0 in 2021, then surged by 2434.34% to $2.1 million in 2022, then rose by 15.2% to $2.4 million in 2023, then advanced by 8.44% to $2.6 million in 2024, then decreased by 21.31% to $2.0 million in 2025.
- Business Quant data shows ANEB's Shares Issued at $2.0 million in Q4 2025, $1.9 million in Q3 2025, and $3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | 3.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.02 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 3.22 Mn |
| Jun 30, 2025 | 3.22 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 705,694.00 |
| Mar 31, 2024 | 705,694.00 |
| Dec 31, 2023 | 2.37 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.05 Mn |
| Sep 30, 2023 | 2.05 Mn |